tert-Butyl (4-ethynylpyridin-3-yl)carbamate

Catalog No.: 
ACGEBD837
CAS No.: 
1038779-11-1
Molecular Formula: 
C12H14N2O2
Molecular Weight: 
218.26
tert-Butyl (4-ethynylpyridin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$117.00InquiryInquiry
1g95%$348.00InquiryInquiry
5g95%$1705.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (4-ethynylpyridin-3-yl)carbamate
IUPAC Nametert-butyl (4-ethynylpyridin-3-yl)carbamate
MDL No.MFCD13189738
Molecular FormulaC12H14N2O2
Molecular Weight218.26
SMILESO=C(OC(C)(C)C)NC1=C(C#C)C=CN=C1
InChI KeyUSDSXQHLSQTXNJ-UHFFFAOYSA-N
Synonymtert-Butyl (4-ethynylpyridin-3-yl)carbamate;Carbamic acid, N-(4-ethynyl-3-pyridinyl)-, 1,1-dimethylethyl ester
CAS No.1038779-11-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGEBD837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLHTV623 route compound structure diagram
    ACLHTV623154048-89-2In Stock
  4. Then
  5. ACGEBD837 route product structure diagram
    ACGEBD8371038779-11-1
Inquiry

2. ACGEBD837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGEBD837 route product structure diagram
    ACGEBD8371038779-11-1
Inquiry

3. ACGEBD837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGEBD837 route product structure diagram
    ACGEBD8371038779-11-1
Inquiry

Comments (0)